University of Notre Dame du Lac’s Acadia Pharmaceuticals ACAD Stock Holding History

University of Notre Dame du Lac’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-23,824	Closed	-$1.01M	–	30
2020 Q1	$1.01M	Buy	23,824 +2,806	+13%	+$116K	0.31%	42
2019 Q4	$899K	Sell	21,018 -9,659	-31%	-$420K	0.28%	50
2019 Q3	$1.1M	Sell	30,677 -113,641	-79%	-$3.45M	0.33%	37
2019 Q2	$3.86M	Buy	144,318 +26,565	+23%	+$679K	0.88%	45
2019 Q1	$3.16M	Sell	117,753 -9,261	-7%	-$216K	0.71%	43
2018 Q4	$2.05M	Buy	+127,014	New	+$2.47M	0.5%	59

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

University of Notre Dame du Lac's ACAD Position: Q2 2020 in Review

University of Notre Dame du Lac sold out of Acadia Pharmaceuticals (ACAD) in Q2 2020, closing a stake of 23,824 shares — an estimated $1.01M sold.

University of Notre Dame du Lac first reported a position in ACAD in Q4 2018 and held it in 6 quarters. The position peaked at $3.86M in Q2 2019. 298 funds tracked by Wall St. Rank hold ACAD as of Q2 2020.

University of Notre Dame du Lac reported no remaining Acadia Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
University of Notre Dame du Lac sold 23,824 Acadia Pharmaceuticals shares in Q2 2020, an estimated $1.01M.
University of Notre Dame du Lac first reported a position in Acadia Pharmaceuticals in Q4 2018 and held it in 6 quarters.
University of Notre Dame du Lac's Acadia Pharmaceuticals position peaked at $3.86M in Q2 2019.
298 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2020.

Based on University of Notre Dame du Lac's 13F filing for Q2 2020, filed 14 Aug 2020.